R&D News | pharmaphorum

News

Rezera, formerly known as NodThera, has announced the terms of its planned IPO, hoping to raise upwards of $200m for its NLRP3 inhibitor pipeline.

News

Two more Ebola vaccines are set to be added to a trial in the Democratic Republic of the Congo (DRC), currently battling its largest-ever outbreak.

News

UK start-up Potential Sciences emerged from stealth today with a sizeable seed funding round and an ambition to transform drug discovery with AI.

News

Two up-and-coming UK biotechs – T-Therapeutics and Alethio Therapeutics – have raised $133m and $90m, respectively, in impressive financing rounds.

News

Boehringer Ingelheim is paying $358m upfront for options on up to six antibody-drug conjugates and T-cell engagers from China's Sino Biopharma.

News

AbbVie has pledged another £120 million to the UK, reinforcing the country's recovery as a pharma industry investment hotspot.